Supplementary Materials

• Supplementary Table 1: Clinical sample characteristics
• Supplementary Table 2: Alternative splicing events displaying significant differences between the normal and cancerous breast tissue training sets
• Supplementary Figure 1: Breast cancer alternative splicing markers
• Supplementary Figure 2: Correlation of alternative splicing events with ER status
• Supplementary Figure 3: Correlation of alternative splicing events with histopathological grade
• Supplementary Figure 4: Correlation of alternative splicing events with PR status
• Supplementary Figure 5: Correlation of alternative splicing events with Her2 status
• Supplementary Figure 6: Correlation of alternative splicing events with tumor size
• Supplementary Figure 7: Correlation of alternative splicing events with tumor type
• Supplementary Figure 8: Correlation of alternative splicing events with node status
• Supplementary Figure 9: Predicted protein isoforms of the 41 breast cancer ASEs
• Legends